Innovative Interventions for Smoking Cessation

• Status: Completed
• Trial end date: 2012-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effect of a combination of the 21 mg nicotine patch and very low nicotine content (VLNC) cigarettes compared to 21 mg nicotine patch only and very low nicotine content cigarette only on abstinence, time to relapse and toxicant levels. The study will determine if adding nicotine replacement medication to the very low content cigarettes (VLNC) will augment treatment compared to nicotine patch only or to very low nicotine content cigarettes only.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Minnesota; University of Minnesota - Clinical and Translational Science Institute
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• a) Smoking at least 10 cigarettes daily for the past year;

• b) In good physical health;

• c) No contraindications for medicinal nicotine; and

• d) Stable, good mental health.

Exclusion Criteria:

• a) Subjects must not be using other tobacco or nicotine products.

• b) Female subjects cannot be pregnant or nursing and must be using appropriate birth control.